National HealthCare Net Worth
National HealthCare Net Worth Breakdown | NHC |
National HealthCare Net Worth Analysis
National HealthCare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including National HealthCare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of National HealthCare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform National HealthCare's net worth analysis. One common approach is to calculate National HealthCare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares National HealthCare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing National HealthCare's net worth. This approach calculates the present value of National HealthCare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of National HealthCare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate National HealthCare's net worth. This involves comparing National HealthCare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into National HealthCare's net worth relative to its peers.
Enterprise Value |
|
To determine if National HealthCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding National HealthCare's net worth research are outlined below:
| National HealthCare generated a negative expected return over the last 90 days | |
| About 61.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: New Hope Co. Limited Announces Interim Dividend of 0.19 |
National HealthCare Quarterly Good Will |
|
National HealthCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in National HealthCare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to National HealthCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 16th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Follow National HealthCare's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.9 B.Market Cap |
|
Project National HealthCare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.06 | |
| Return On Capital Employed | 0.07 | 0.12 | |
| Return On Assets | 0.07 | 0.06 | |
| Return On Equity | 0.10 | 0.15 |
When accessing National HealthCare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures National HealthCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of National HealthCare's profitability and make more informed investment decisions.
Please note, the presentation of National HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National HealthCare's management manipulating its earnings.
Evaluate National HealthCare's management efficiency
National HealthCare has Return on Asset of 0.0288 % which means that on every $100 spent on assets, it made $0.0288 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1324 %, implying that it generated $0.1324 on every 100 dollars invested. National HealthCare's management efficiency ratios could be used to measure how well National HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, National HealthCare's Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, National HealthCare's Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.13, whereas Total Assets are forecasted to decline to about 798.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 63.87 | 67.06 | |
| Tangible Book Value Per Share | 51.50 | 54.08 | |
| Enterprise Value Over EBITDA | 9.83 | 5.75 | |
| Price Book Value Ratio | 1.69 | 1.96 | |
| Enterprise Value Multiple | 9.83 | 5.75 | |
| Price Fair Value | 1.69 | 1.96 | |
| Enterprise Value | 1.8 B | 1.9 B |
Examining the leadership quality of National HealthCare offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 1.1242 | Revenue | Quarterly Revenue Growth 0.179 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on National HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases National HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
National HealthCare Corporate Filings
F4 | 6th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 3rd of March 2025 An amendment to a previously filed Form 10-K | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
National HealthCare Earnings per Share Projection vs Actual
National HealthCare Corporate Executives
Elected by the shareholders, the National HealthCare's board of directors comprises two types of representatives: National HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National HealthCare's management team and ensure that shareholders' interests are well served. National HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.021 | Dividend Share 2.4 | Earnings Share 7.99 | Revenue Per Share | Quarterly Revenue Growth 0.179 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.